Pages that link to "Q28588039"

The following pages link to IL-33 induces nuocytes and modulates liver injury in viral hepatitis. (Q28588039):

Displaying 42 items.

• Interleukin 33 (Q21495879) (← links)
• The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response (Q26743383) (← links)
• Endogenous IL-33 Deficiency Exacerbates Liver Injury and Increases Hepatic Influx of Neutrophils in Acute Murine Viral Hepatitis (Q33760241) (← links)
• The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases (Q33790954) (← links)
• Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation (Q33808159) (← links)
• Strong type 1, but impaired type 2, immune responses contribute to Orientia tsutsugamushi-induced pathology in mice (Q34257323) (← links)
• Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases (Q35439783) (← links)
• Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation (Q35754479) (← links)
• IL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected Mice (Q35946057) (← links)
• Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis (Q36302605) (← links)
• The role of IL-33 in rheumatic diseases (Q37208870) (← links)
• Regulation of metabolic health and adipose tissue function by group 2 innate lymphoid cells (Q37313634) (← links)
• IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis (Q37376114) (← links)
• The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment. (Q37571181) (← links)
• Intrahepatic innate lymphoid cells secrete IL-17A and IL-17F that are crucial for T cell priming in viral infection. (Q37668196) (← links)
• IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism (Q37727601) (← links)
• Liver fibrosis and repair: immune regulation of wound healing in a solid organ (Q38190875) (← links)
• The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells. (Q38224933) (← links)
• Group 2 innate lymphoid cells in health and disease (Q38312434) (← links)
• Pivotal roles of ILCs in hepatic diseases (Q38366661) (← links)
• Group 2 innate lymphoid cells in disease (Q38573631) (← links)
• Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes. (Q38810636) (← links)
• Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure. (Q38851740) (← links)
• Retinoic Acid Regulates Immune Responses by Promoting IL-22 and Modulating S100 Proteins in Viral Hepatitis. (Q38863916) (← links)
• Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection. (Q38908828) (← links)
• Adverse outcome pathway development from protein alkylation to liver fibrosis (Q38932043) (← links)
• Emerging concepts in biliary repair and fibrosis (Q39319145) (← links)
• IL-33 promotes innate IFN-γ production and modulates dendritic cell response in LCMV-induced hepatitis in mice (Q39673177) (← links)
• Oncostatin M induces IL-33 expression in liver endothelial cells in mice and expands ST2+CD4+ lymphocytes (Q40649385) (← links)
• Expression and potential roles of IL-33/ST2 in the immune regulation during Clonorchis sinensis infection (Q40767311) (← links)
• Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation (Q41149769) (← links)
• Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B. (Q41228712) (← links)
• IL-33-ST2 Axis in Liver Disease: Progression and Challenge (Q47127784) (← links)
• Unconventional Pro-inflammatory CD4+ T Cell Response in B Cell-Deficient Mice Infected with Trypanosoma cruzi. (Q47162312) (← links)
• Dysregulated Th1 Immune and Vascular Responses in Scrub Typhus Pathogenesis (Q50066285) (← links)
• IL-33 induces immunosuppressive neutrophils via a type 2 innate lymphoid cell/IL-13/STAT6 axis and protects the liver against injury in LCMV infection-induced viral hepatitis. (Q50199697) (← links)
• Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma. (Q52141871) (← links)
• Ambiguous roles of innate lymphoid cells in chronic development of liver diseases. (Q55208795) (← links)
• Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future Perspectives (Q64251722) (← links)
• In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity (Q90376122) (← links)
• The Roles of Liver-Resident Lymphocytes in Liver Diseases (Q92404793) (← links)
• Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4+ T cells (Q92890876) (← links)